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Abstract 
The proper care of cystic fibrosis patients extends over their lifetime. More than half of the children with the disease die before 
adulthood. An important element in the patient’s care is a time of transition from a paediatric to the care of an internist and the 
patient’s acceptance of this necessity. Transition from paediatric care to an internist should be adequately prepared. It is not only 
a question of transfer of medical records, but also careful preparation of patients for such transition. The patients expect not only 
continuity of care but also the introduction to the management with the disease. The creation of a base for specialist hospital 
treatment for exacerbation of the disease at the adulthood is an important element in the care of these patients. The problem has 
been solved in the children group, but is still waiting for solution in adults with cystic fibrosis. It has been proven that care in the 
centres carried out by a specialized team ensures longer life and better quality of life of these patients. The paper is an overview 
of these two important elements of care of adults with cystic fibrosis. 
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Introduction
In Poland, cystic fibrosis (CF) affects ap-
proximately one in every 4,400 births [1]. In 
statistical terms, there are around 80 babies with 
cystic fibrosis born each year. The Polish popu-
lation of patients with CF is estimated at around 
1,500 (according to the CF Patients Register of the 
Polish Cystic Fibrosis Society; some of the listed 
paediatric patients are found to have unknown 
mutations and are subject to clinical observation). 
However, the statistics only include diagno-
sed patients. Until recently, CF was diagnosed 
within the first two years of life in a clear majority 
of cases. Since mid-2009, newborn screening for 
selected congenital diseases, including cystic 
fibrosis, has been under way all over Poland. The 
currently used highly sensitive screening model 
makes it highly unlikely to detect any cases of 
CF in the paediatric population who have tested 
negative. However, there are still cases where CF 
is diagnosed in individuals who have not been 
screened (born before July 1st 2009), including 
adults (which represent around 2.5% of all dia-
gnosed cases). 
Overall, the annual incidence rate of CF is in 
Poland is estimated at around 70−80 new cases. In 
2011, adult patients represented over one third 
of the total CF population of over 500 patients 
in Poland, which makes it clear that physicians 
specifically trained in the management of adult 
patients should have at least 60 new cases per year.
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A mean age of CF population is 14.4 years; aro-
und 35% of cystic fibrosis patients are adults [2].
 A median age of patients with CF in 2003 was 
16.3 years ± 4.9 and differed between coun-
tries. In UE countries it amounted to 17 years, 
in non-EU countries  it amounted to 12.1y. Data 
were collected from 35 countries on the basis of 
information about 29,025 patients. In the UE, 
patients aged 18−40 years accounted for 42% of 
all patients, in countries outside the EU — 26%. 
Accordingly, patients over 40 years of age ac-
counted for 5% of all patients in the UE and 2% 
of all patients in the countries outside the EU, 
Poland has not been included in the analysis [3]. 
Other data confirmed the increase in the 
average lifespan time of patients with CF in re-
cent decades.
Based on data collected from 10 countries in 
the years 1980 to 1994,  a median age of patients 
who died in 1974 was eight years and 21 years 
in 1994. These results vary between countries 
and  have been shown to largely depend on the 
CF patient care system [4].
It is estimated that in 2025, in comparison 
with 2010, the number of patients over 18 years 
in Poland will increase by approx. 15.4%. Rating 
for our country is difficult due to incomplete 
epidemiological data [5].
In Denmark, where 75% of CF patients are 
managed at a single CF specialist centre, around 
80% of patients are predicted to survive until 
50 years of age due to aggressive treatment they 
receive [6].
Apart from new treatment options, there are 
two other factors that play a pivotal role in incre-
asing the life expectancy of CF patients.
Transitional care is one of the basic issu-
es, with a  focus on patient preparation for the 
transition from paediatric to adult care (and its 
acceptance by the patient).
There can be also certain organisational pro-
blems involved in adult CF patient management.
The challenges of chronic care for patients  
during adolescence
For many years now, comprehensive paedia-
tric care for CF patients has been well-established 
and accessible at several CF centres within pa-
ediatric hospitals all over Poland. 
Just like in any other chronic condition, he-
alth-related quality of life in cystic fibrosis is of 
particular significance in early adulthood when 
the simultaneous developmental and psychoso-
cial transitions from childhood to adulthood are 
taking place. Patients continue university edu-
cation or enter the labour market, establish new 
relationships, and to address their new needs, 
they are transferred to a new healthcare facility 
dedicated specifically to adults patients. Unless it 
is managed in a skilful and professional manner, 
the transition from paediatric to adult care can 
add extra stress to patients, or increase the risk 
of patient mismanagement, and therefore may 
have some adverse consequences for patient 
health [7−9]. The transitional care is defined 
as a pre-planned, comprehensive, and active 
healthcare process offering young patients with 
chronic illness the chance to develop their heal-
thcare-related skills and knowledge during the 
difficult period of adolescence. As such, patient 
care in the transitional period should be well 
adapted to psychosocial, educational and profes-
sional needs of adolescents [8−12].
Although a number of healthcare centres 
where CF patients are managed have the ne-
cessary experience in transitional care, or even 
dedicated transitional care programmes, what is 
missing is a uniform approach to patient support 
in adolescence and to teaching patients the skills 
of self-care [13]. The few studies that have been 
published have shown a number of shortcomings 
in the transition from paediatric to adult care that 
can negatively affect the experience of adolescent 
patients in this critical period of life [7−10, 12].
The basic assumptions of transitional care 
programmes for CF adolescents are basically 
consistent with other programmes designed for 
chronically ill patients. These are in particular:
—  adapting the patient care system in an age
-appropriate way 
—  supporting the development of communi-
cation and decision-making skills to boost 
self-assurance and assertiveness of patients
—  developing the sense of control and indepen-
dence, both in the healthcare system and in 
personal life
—  improving the life opportunities and the 
quality of life [11].
Health-related effects on the quality of life 
during adolescence
According to paediatric care, adolescence is 
the period of transition from childhood to adu-
lthood taking place between 12 and 19 years of 
age. Young people between 16 and 19 years of age 
develop their own unique identity. During that 
time, a chronic condition can have a significant 
impact on the physical, emotional and mental 
development of a young individual. Therapeu-
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tic management can be negatively affected by 
behaviours that can be typical of adolescents 
(sluggishness, forgetfulness, absent-minded-
ness, non-adherence, nonconformist approach). 
The priorities of adolescents and their parents 
or carers start to diverge. Adolescents typically 
strive for independence, and do not perceive the 
warnings of complications, permanent impair-
ment, or even death from non-adherence as any 
imminent threats. Therapeutic problems may 
arise, which makes it even more difficult to make 
young patients aware of the importance of regular 
treatment [14]. The discipline and sacrifices of 
life of patients suffering from a chronic condition 
collide with the challenges of adolescence. In the 
first years of adolescence, when young people 
are preoccupied with the physical development 
of their body, some CF patients may be seriously 
concerned over their delayed growth and pubertal 
development. Their personal independence can 
be limited by frequent pulmonary exacerbations, 
and the resulting intensive treatment and hospi-
talization, which may accentuate the feeling of 
being different from their peers. Young patients 
with CF find it difficult to plan for the future due 
to frequent cases of infertility, genetic implica-
tions of CF, and shorter life expectancy [11].
Certain practical questions arise in the face 
of the challenges of the transitional period. The-
re are issues such as when and how to prepare 
patient for the transition from paediatric to adult 
care, what is the best time of transition, and what 
is the role of a paediatrician, internists, and other 
healthcare professionals involved in the tran-
sition process. 
Preparation of patients for the transition 
from paediatric to adult care
The patient transition should start as early as 
possible, preferably at the age of 11/12 years. The 
transition process should be supervised by a mul-
tidisciplinary team of healthcare professionals: 
physicians, nurses, physiotherapists, social as-
sistants, and occupational therapists. The process 
should also involve the families of patients, but 
only upon prior patient’s consent. The transition 
process should preferably take place in the pe-
riod of remission. Adolescent patients should be 
comprehensively informed of the nature of the 
disease, its treatment and prognosis, as well as 
therapy-related benefits and risks. Plans for the 
future should be discussed with the patient, ta-
king into account the patient’s interests. Patients 
should be also made aware that they should beco-
me self-dependent. Another important step is to 
provide patients with psychological support and 
convince them to visit their doctor regularly [8, 9, 
11, 14]. An example of progressive development 
of patient’s independence in self-care is provided 
in Table 1.
The preferable time of transition from pa-
ediatric to adult care is 16 to 18 years of age. 
In any case, account must be taken of the pa-
tient’s personality and health status, especially 
in terms of physical, psychosexual, social and 
professional maturity [14, 15]. In the conditions 
of healthcare and education systems in Poland, 
it must be borne in mind that the preferred age 
of transition coincides with intensive school 
education, and the high level of anxiety related 
to the Matura examinations examinations, as well 
professional or educational choices. 19-year old 
patients typically change school and move home, 
and become more self-dependent. Thus, 19 years 
of age appears to be the best time for transition, 
preferably in the period of remission (Table 1).
Recommendations for transitional care
Recommendations for patient care in adole-
scence can facilitate transition to adult care [11, 
13, 15]. Mutual trust and respect in the patient-
physician relationship is one of the cornerstones 
of proper patient care. Many teenagers perceive 
the qualities and personality of a physician as 
a key determinant of transitional care. It is diffi-
cult to win the trust of adolescent patients if they 
suspect some information can be shared with 
their parents instead of being discussed with them 
alone. Notwithstanding the different behaviours 
which can be expected of adolescent patients, 
any type of prejudice towards patients should 
be avoided. Patient care should be continuous 
and coherent. Young patients need around 4 or 
5 visits to make sure that a doctor can be trusted. 
Visits should be arranged in absence of parents, 
and the scheduled appointment time should be 
longer than the time typically devoted to adu-
lts and paediatric patients. Also, the relevant 
health problems, such as addictions, sexuality, 
emotional and psychological instability should 
be taken seriously, which is another precondition 
for establishing mutual trust in the patient-phy-
sician relationship. Adolescent patients should 
be preferably made personally responsible for 
monitoring their health condition, and should be 
made prepared to take medications and manage 
rehabilitation in an unsupervised manner. In 
essence, young patients should be made aware 
of the importance of regularity and discipline in 
managing their condition [14]. Also, they should 
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understand that effective disease management 
crucially depends on their active involvement 
in therapy. 
HEADSS for Adolescents [16] is an interview 
instrument which can be used in daily clinical 
practice and can be adapted accordingly to exami-
ne and discuss adolescents’ family relationships, 
family support and household chores (H — home), 
education, work and expectations for the future 
(E — education), rehabilitation (E — exercise), perso-
nal interests (A — activities), friendship and aspira-
tions (A — affect, ambitions), dental care, drugs, diet, 
body weight control (D — dental care, diet, drugs), 
sexuality (S — sex), and sleep patterns (S — sleep). 
Transfer of medical records
Patient transition from paediatric to adult 
care is essentially based on the transfer of medi-
cal records. Patient records, the so-called Cystic 
Fibrosis Passport, should include full patient 
history: type of disease, date of diagnosis, exami-
nation results, disease progress, complications, 
therapies, medical procedures, rehabilitation 
recommendations, and the current health sta-
tus, together with the latest medical check-ups 
(diagnostic imaging) and a  treatment plan. The 
transition procedure should be harmonized and 
unified [8, 9]. Paediatricians can be expected to 
prepare adolescent patients and their closest re-
latives for the transition and self-care, and should 
inform internists in advance (6–12 months) of 
the planned patient transition, which should be 
scheduled to take place, to the extent possible, 
during the period of CF remission. It should be 
accompanied by the transfer of medical records 
(CT Passport), establishment of a treatment plan, 
and provision of contact details (phone number, 
e-mail address of the paediatrician). At best, phy-
sicians / patient management team should liaise 
closely to review the case [15]. Also, patients 
should not be excessively and repeatedly investi-
gated during the transitional period. On patient 
transition, the internist should focus on conti-
nuity of care, and should progressively prepare 
the patient for independence and self-reliance in 
the disease management.
The challenges of adult patient care  
in cystic fibrosis 
At present, adult patient care is in the ma-
jority of cases continued at paediatric units (the 
paediatric care centre in Rabka, Poland, has 
around 166 adult patients, in Gdańsk — 48, in 
Karpacz — 24). 
Adult CF patients can be provided with 
continuous treatment at only a few pulmonology 
units for adults: 85 patients in Poznań — at a te-
aching hospital, 100 patients at the Institute of 
Tuberculosis and Lung Diseases in Warsaw, and 
a small group of patients in Białystok and Zabrze, 
along with single cases managed at pulmonology 
wards scattered all over Poland.
Apart from the continuity of outpatient care, 
a major difficulty arises with respect to hospitali-
zation of patients with exacerbation of the chronic 
obstructive bronchopulmonary disease. The two 
biggest pulmonology units for adults (Poznań and 
Warsaw) are unable to meet the demands and 
needs of such patients for reasons of: 1) limited 
number of beds, 2) contractual limitations, 3) 
and lack of inpatient isolation rooms for adults 
with CF. 
It is worth noting, however, that no distinc-
tion is made between specific diagnoses under 
the National Health Fund (NFZ, Narodowy Fun-
dusz Zdrowia) contracts with hospitals, and the 
treatment of CF exacerbations (lasting more than 
2 days) is awarded 188 points (E84 is the under-
lying diagnosis!). In terms of patient isolation, 
this precaution is intended to protect CF patients 
against infectious agents transmitted by other 
patients (patients with infectious tuberculosis) as 
well as vulnerable (immunosuppressed) patients 
against pathogens transmitted by CF patients. The 
current epidemiological standards can be assu-
med to provide proper conditions for safe hospita-
lization of CF patients in any inpatient pulmonary 
unit. Another benefit of inpatient isolation rooms 
is that patients with CF are offered better comfort 
of care (a single room with private en suite toilet 
and bathroom).
To provide for optimum adult CF patient 
care in the years to come, it would be necessary 
to establish hospitalization options and compre-
hensive patient care at several pulmonary centres 
for adult patients all over Poland. Healthcare 
centres in Lublin, Zabrze, Białystok, Gdańsk, 
and Radom have been interested in developing 
this type of care. In the coming months, the ma-
jor challenge would be to encourage physicians 
and other healthcare professionals, along with 
all decision-makers, to express their willingness 
and invite the existing healthcare centres to set 
up satellite CF units. The new CF units should 
be established as an integral part of the existing 
pulmonary centres and should operate, for exam-
ple, as semi-independent entities within hospitals 
for patients with pulmonary insufficiency suffe-
ring from other underlying pulmonary diseases, 
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although other organizational challenges will 
definitely arise in the long run. As evidenced 
from the organizational experience of other 
countries with well-established CF patient care 
system, an optimum solution is where specialist 
patient care is managed by a multidisciplinary 
team of experienced healthcare professionals at 
CF centres [17]. Specialist care in dedicated CF 
centres is associated with improved survival and 
quality of life [18].
This strategy has been based on the Stan-
dards of care for patients with cystic fibrosis: an 
European consensus [19, 20]. A CF centre should 
normally care for a minimum of 50 patients. The-
re are ready-made organizational solutions and 
requirements for both the staff (multidisciplinary 
teams) and healthcare facilities already in place.
Apart from inpatient isolation rooms for adu-
lts with CF, CF centres dedicated to adult patients 
should offer:
—  an inpatient ward and a day-care ward,
—  outpatient care facilities, 
— an intensive care unit (basic condition),
—  a radiology department (X-ray, CT),
—  laboratory and microbiological facilities,
—  expertise in bronchoscopy and other endo-
scopic techniques,
—  expertise in nutrition support techniques,
—  expertise in endovascular techniques (ob-
literation of bronchial arteries) in at least 
2 selected centres (currently available in 
Lublin and Poznań)
—  full diagnostic capability, including functio-
nal tests of the respiratory system,
—  expertise in implantation and maintenance 
of vascular access ports,
—  physiotherapy facilities,
—  expertise in home oxygen therapy and me-
chanical respiratory assistance facilities,
—  patient preparation for lung transplant and 
post—transplant care.
As a  rule, inpatient pulmonary wards in 
Poland meet the conditions listed. Apart from 
standard pulmonary care (over 90% of respiratory 
insufficiencies can be life-limiting conditions), 
pulmonary clinics should also offer consultations 
in ENT, gastroenterology, nutrition, diabetology, 
gynaecology and obstetrics, and andrology (ada-
pted to the individual patient’s needs).
Effective patient care can be only provided 
by healthcare facilities having appropriate space 
and equipment, as well as trained and dedicated 
physiotherapists, nurses, dieticians, psycholo-
gists, other professionals offering spiritual and 
social support, as well as office staff. Pharmacists 
must be also involved in the establishment of 
new CF centres. 
To operate successfully, CF centres must 
obviously employ physicians who are fully com-
mitted to CF patient care, but must be also 
supported by the hospital’s executive staff, who 
must be fully aware of the challenges and ca-
pable of providing support. On the other hand, 
decision-makers who work to set up a CF centre 
should be conscious of the actual financial con-
text of the project, and should be co-responsible 
for its financial condition.
CF centres should provide inpatient care, 
outpatient care and the combined inpatient and 
home care, as well as home care options. Anti-
biotic therapy options available in home care 
(following slight modifications in the currently 
proposed model) can offer patients the chance to 
stay at home in the exacerbation period, unless 
hospital care is essentially required, which could 
take the burden off hospital.
Pulmonologists who have never dealt with 
adult patients with CF may find it difficult to 
understand the level of difficulty associated with 
patient transition from paediatric to adult care. 
They simply fail to fully comprehend the organi-
zational and psychological aspects of patient care 
in a chronic disease, requiring full engagement of 
patient and family, often involving close relation-
ships with paediatricians and other healthcare 
professionals, built on shared experienced and 
the special (and well-deserved) privileged po-
sition of chronically ill patients. 
Moreover, it cannot be denied that some 
pulmonologist may fear that the problems of CF 
patients, most notably the organizational chal-
lenges and the financial burden of CF therapy, 
may dominate their working environment where 
the needs of other groups of patients cannot be 
left unanswered. 
It needs to be clearly stated that there is no 
chance of an effective and comprehensive care 
for adolescents with cystic fibrosis, while main-
taining the relations which typically dominate at 
adult wards, where we deal with patients with 
mature and established personality. A CF centre 
cannot be successfully operated unless a sensitive 
approach to CF patients is adopted, and full dedi-
cation is always given to both patients and their 
families. This approach needs to be adopted not 
only by physicians who often feel overwhelmed 
by the challenges of managing such complicated 
and time-consuming cases (and can feel intimi-
dated by the extent to which patients and their 
families are familiar with this multidimensional 
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condition), as well as all healthcare professionals 
engaged in comprehensive medical care. 
It is hardly conceivable to abandon efforts 
to provide CF patients with optimum care or to 
offer them special preferences in the face of the 
challenges they have before them, although their 
life is often very short. 
The challenge ahead — which is currently 
one of the basic tasks of pulmonologists man-
aging adult patients in Poland, and one of the 
most challenging healthcare issues in patient 
care – will involve organizational zeal, a multi-
tude of concerted initiatives, and institutional 
support (for example within the framework of 
the national CF patient care programme), taken 
independently or as part of the national pulmo-
nology programme. The initiative to create and 
accept projects related to CT patient care can be 
supported by national and regional consultants, 
scientific societies, patients’ associations, as well 
as non-governmental organisations. 
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